Wada, Hideki
Miyauchi, Katsumi
Suwa, Satoru
Miyazaki, Sakiko
Hayashi, Hidemori
Nishizaki, Yuji
Yanagisawa, Naotake
Yokoyama, Katsuaki
Murata, Nobuhiro
Saito, Yuki
Nagashima, Koichi
Matsumoto, Naoya
Okumura, Yasuo
Minamino, Tohru
Daida, Hiroyuki
Funding for this research was provided by:
Abbott Japan
Astellas Pharma
AstraZeneca
Bayer Healthcare
Boehringer Ingelheim Japan
Boston Scientific Corporation
Bristol Myers Squibb Foundation
Crosswill Medical
Daiichi-Sankyo
Eisai
Fukuda Denshi
FUJIFILM RI Pharma
Japan Lifeline
Kowa Pharmaceutical
Kyowa Hakko Kirin
Mitsubishi Tanabe Pharma Corporation
Mochida Pharmaceutical Company
Medical Hearts
Medtronic Japan
MSD
Nippon Shinyaku
Otsuka Pharmaceutical
Pfizer
Philips Respironics
Roche Diagnostics
Sanwa Kagaku Kenkyusho
Sanofi
Shionogi
Dainippon Sumitomo Pharma
Takeda Pharmaceutical Company
Nihon Medi-Physics
Article History
Received: 9 April 2024
Accepted: 24 July 2024
First Online: 6 August 2024
Declarations
:
: Dr. Daida has accepted remuneration from Daiichi-Sankyo, Kowa, MSD, Novartis Pharma, and Bayer Yakuhin, Sanofi K.K., Taisho Pharmaceutical, Abott Medical, Otsuka, Amgen K.K., Pfizer, Fukuda Denshi, Tsumura, Toa Eiyo; received research grants from Philips Japan, Toho Holdings, Asahi Kasei, Fujifilm holdings; Inter Reha, Glory, BMS, Abott, and Boehringer Ingelheim and received scholarship funds from Daiichi-Sankyo, Bayer Yakuhin, and Eisai. Dr. Matsumoto has lecture’s fee from Nihon Medi-physics and PDRadio Pharma, and has received scholarship donation from PDRadio Pharma. Dr. Miyauchi has accepted remuneration from Astellas, MSD, Bayer Yakuhin, Sanofi, Daiichi-Sankyo, Boehringer-Ingelheim, and Bristol-Myers Squibb. Dr. Minamino serves as a consultant to Fukuda Denshi; has accepted remuneration from Kowa, Mitsubishi Tanabe, Daiichi-Sankyo, Bayer Yakuhin, Boehringer-Ingelheim, AstraZeneca KK, Medtronic Japan, Otsuka, Novartis Pharma, Takeda, MSD, Actelion, and Biotronik Japan; accepted research grants from Boehringer-Ingelheim, Bourbon Corporation, and Astellas Pharma; and received scholarship funds from Medical Hearts, Abbott Medical Japan, Japan Lifeline, Medtronic Japan, Mochida, Roche Diagnostics, Takeda, Crosswill Medical, Daiichi-Sankyo, Boehringer-Ingelheim, Boston Scientific Japan, Kowa, Otsuka, Bristol-Myers Squibb, Fukuda Denshi, and Astellas. Dr. Okumura has received research funding from Bayer Healthcare and Biosense Webster, Inc., scholarship donation from Boston Scientific Japan, and Endowed Courses from Boston Scientific Japan, Japan life line, Fukuda Denshi, Abbott Japan, BIOTRONIK Japan, Medtronic Japan, and has accepted remuneration from Bayer Healthcare, Daiichi-Sankyo, Bristol-Meyers Squibb, AstraZeneca K.K., Ono Pharmaceutical, and Medtronic Japan.